Bingliang Fang 
Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
HomePage
Research Interests
innovative anticancer agents, targeted cancer therapy, the mechanisms of action of and/or resistance to anticancer agents, molecular signatures or biomarkers for predicting treatment response or early diagnosis of lung cancers
Contributions:
Special Issue:
